The 2023 ACR/EULAR classification criteria of CPPD [14]

Criteria
Entry criterion
- Ever had at least one episode of joint pain, swelling, or tenderness (in a peripheral joint or axial joint such as C1/C2 in the case of crowned dens syndrome).
Absolute exclusion criteria
- All symptoms more likely explained by an alternate condition (e.g., rheumatoid arthritis, gout, psoriatic arthritis, OA, etc.).
Sufficient criteria
- Crowned dens syndrome (as characterized by both clinical and imaging features).
- Synovial fluid analysis demonstrating CPP crystals in a joint with swelling, tenderness or pain.
Additional classifications
- An individual is classified as CPPD if the entry criterion is met, exclusion criteria are not met, and at least one sufficient criterion is fulfilled.
- If none of the sufficient criteria are present, an individual is classified as CPPD disease if the sum of the criteria below is > 56 points.
Scoring guidelines
- Items can be scored if they were ever present during a patient’s lifetime.
- If a patient fulfills > 1 item in a given domain, only the highest weighted item will be scored.
- Imaging of at least one symptomatic joint by CR, US, CT, or DECT is required.
Domains and levelsPoints
A. Age at onset of joint symptoms
≤ 60 years0
> 60 years4
B. Time-course and symptoms of inflammatory arthritis
No persistent or typical inflammatory arthritis0
Persistent inflammatory arthritis (ongoing joint swelling with pain and/or warmth in one or more joints)9
1 typical acute arthritis episode (episode with acute onset or acute worsening of joint pain with swelling and/or warmth that resolves regardless of treatment)12
More than 1 typical acute arthritis episode16
C. Sites of typical episode(s) of inflammatory arthritis in peripheral joints
1st MTPJ-6
No typical episode(s)0
Joint(s) other than wrist, knee, or 1st MTPJ5
Wrist8
Knee9
D. Related metabolic diseases (hereditary hemochromatosis, primary hyperparathyroidism, hypomagnesemia, Gitelman syndrome, hypophosphatasia, or a familial history of CPPD disease)
None0
Present6
E. Synovial fluid crystal analysis from a symptomatic joint
CPP crystals absent on ≥ 2 occasions–7
CPP crystals absent on 1 occasion–1
Not performed0
F. OA of hand/wrist on imaging
None of the following findings or no wrist/hand imaging performed0
Bilateral radio-carpal joints2
≥ 2 of the following: STTJ OA without 1st CMCJ OA; 2nd MCPJ OA; 3rd MCPJ OA7
G. Imaging evidence of CPPD in symptomatic peripheral joint(s)
None on US, CT, or DECT (and absent on CR or CR not performed)–4
None on CR (and US, CT, DECT not performed)0
Present on either CR, US, CT, or DECT16
H. Number of peripheral joints with evidence of CPPD on any imaging modality
None0
116
2–323
≥ 425

ACR: American College of Rheumatology; EULAR: European League Against Rheumatism; CPPD: calcium pyrophosphate deposition disease; CPP: calcium pyrophosphate; CR: conventional X-ray radiography; US: ultrasound; CT: computed tomography; DECT: dual-energy computed tomography; MTPJ: metatarsophalangeal joint; OA: osteoarthritis; STTJ: scaphotrapeziotrapezoid joint; CMCJ: carpometacarpal joint; MCPJ: metacarpophalangeal joint

Note. Adapted with permission from “The 2023 ACR/EULAR classification criteria for calcium pyrophosphate deposition disease” by Abhishek A, Tedeschi SK, Pascart T, Latourte A, Dalbeth N, Neogi T, et al. Ann Rheum Dis. 2023;82:1248–57 (https://ard.bmj.com/content/82/10/1248). © Author(s) (or their employer(s)) 2023.